EUVIMEDObjevte EUVIMED
Open access

The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway

Yuehong Tong, Lili Xu, YiQun Sun, Keke Zhang, Xiaoyan Fu iD

Immunology & Cell Biology · 2026

DOI: 10.1111/imcb.70152 ↗

At a glance

Journal article in Immunology & Cell Biology, 2026. Written by Yuehong Tong and 4 co-authors. Institution: Department of Gynaecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China. Major MEDLINE topics: Endometrial Neoplasms, Protein Serine-Threonine Kinases, Adenosine. 33 references. The full text is freely available in PubMed Central. Funded by: the Key Project of Social Development Category in Jinhua Science and Technology Plan.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

This study investigates the role of CIT gene in uterine corpus endometrial carcinoma (UCEC) progression, focusing on its regulation by m6A methylation. Bioinformatics and experimental analyses (EdU, colony formation assay, Dot blot, MeRIP‐PCR, RNA pull‐down, qRT‐PCR, Western Blotting, apoptosis assay) revealed that CIT was significantly overexpressed in UCEC. Mechanistically, we found that the m6A writer RBM15‐mediated CIT mRNA methylation, which was then recognized by the reader IGF2BP1 to enhance CIT mRNA stability and expression. Consequently, this m6A‐mediated upregulation of CIT inhibited the Hippo signaling pathway, ultimately suppressing apoptosis and promoting malignant proliferation in UCEC. These findings elucidated a novel RBM15/IGF2BP1‐CIT‐Hippo axis, providing new theoretical insights and potential therapeutic targets for UCEC.

Subjects

MeSH terms (MEDLINE)

Endometrial NeoplasmsProtein Serine-Threonine KinasesAdenosineFemaleHumansHippo Signaling PathwayDisease ProgressionGene Expression Regulation, NeoplasticSignal TransductionRNA-Binding ProteinsRNA MethylationCell ProliferationCell Line, TumorApoptosisAnimalsRNA, Messenger

Author keywords

CITN6‐methyladenosinehippo signaling pathwayuterine corpus endometrial carcinoma

Substances

Protein Serine-Threonine KinasesN-methyladenosineAdenosineRNA-Binding ProteinsRNA, Messenger

Authors and institutions

  • Department of Gynaecology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
  • Department of Gynaecology, Jinhua Maternal and Child Health Care Hospital, Jinhua, Zhejiang, China.
  • Medical Molecular Biology Laboratory, Medical College, Jinhua University of Vocational Technology, Jinhua, Zhejiang, China.

ORCID profiles: Xiaoyan Fu

Funding

  • the Key Project of Social Development Category in Jinhua Science and Technology Plan

Cite

APA

Tong, Y., Xu, L., Sun, Y., Zhang, K., & Fu, X. (2026). The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70152

Vancouver

Tong Y, Xu L, Sun Y, Zhang K, Fu X. The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway. Immunology & Cell Biology. 2026. doi:10.1111/imcb.70152

BibTeX
@article{Tong2026,
  author = {Tong, Yuehong and Xu, Lili and Sun, YiQun and Zhang, Keke and Fu, Xiaoyan},
  title = {The N6‐Methyladenosine‐Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway},
  journal = {Immunology & Cell Biology},
  year = {2026},
  doi = {10.1111/imcb.70152}
}
Start for free →